サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1675319

消化管用OTC医薬品市場：薬剤クラス別、適応症別、エンドユーザー別、地域別、2025-2033年

Gastrointestinal OTC Drugs Market by Drug Class, Indication (Gastroesophageal Reflux Disease or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
消化管用OTC医薬品市場：薬剤クラス別、適応症別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年03月01日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

消化管用OTC医薬品市場の世界市場規模は2024年に437億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに622億米ドルに達し、2025年から2033年にかけて3.82%の成長率（CAGR）を示すと予測しています。胃腸疾患の有病率の上昇、消化器系の健康に対する大衆の意識の高まり、最近の高度な製剤の開発が市場を牽引する主な要因となっています。

消化管用OTC医薬品とは、胃腸の症状を緩和し、全体的な消化器系の健康を促進する非処方薬を指します。下剤、制酸剤、H2ブロッカー、プロトンポンプ阻害剤（PPI）、制吐剤、腸抗炎症剤、下痢止めなどが含まれます。消化管用OTC医薬品は、消化不良、便秘、胸やけ、下痢、乗り物酔い、酸逆流、吐き気、過敏性腸症候群（IBS）、腹痛などの治療に広く使われています。費用対効果が高く、便利で簡単に入手できる製品であり、即効性のある緩和をもたらし、患者の快適性を高め、自己管理を可能にします。消化管用OTC医薬品はまた、腸内環境を改善し、有益な細菌を回復させ、将来の合併症を予防し、痛み、腹部膨満感、腹部不快感、嘔吐などのさまざまな症状の重症度を最小限に抑えるのに役立ちます。

消化管用OTC医薬品市場傾向：

座りがちなライフスタイルや不健康な食習慣による胃腸障害の有病率の上昇は、市場の成長を後押しする重要な要因のひとつです。消化管用OTC医薬品は、感染症、消化不良、急性下痢、胸やけ、胃食道逆流症（GERD）、便秘、腹部膨満感、つわりなどの治療に広く使用されています。さらに、消化を改善し、腸の健康を促進し、栄養素の適切な分解と吸収を確保するための製品用途の増加は、消化の健康に対する大衆の意識の高まりに起因しており、市場成長の原動力となっています。これに伴い、健康状態を管理し将来の健康合併症を予防するためのセルフケアと消費者のエンパワーメントという新たな動向が、もう一つの成長誘発要因として作用しています。さらに、最近の発泡性錠剤、液剤、懸濁剤、フィルムストリップ、チュアブル製品などの高度な製剤開発は、薬剤の有効性を高め、吸収を高め、投与回数を減らすものであり、市場成長にプラスの影響を与えています。これに加えて、ブリスターパック、リシーラブルパウチ、1回投与分包などの便利で旅行しやすいパッケージングの導入が市場成長を促進しています。これとは別に、非侵襲的治療に対する消費者の嗜好の高まりが、一般的な消化器系の問題を管理し、即座に緩和を提供する製品需要を促進しています。さらに、複数のメーカーによるテレビ（TV）コマーシャル、ソーシャルメディア、インフルエンサーマーケティング、有名人の推薦を通じた積極的なプロモーションやブランディングキャンペーンが市場成長を強化しています。その他、老年人口の増加、消費者の支出能力の増加、eコマースプラットフォームでの製品の容易な入手などが市場成長を促進すると予想されます。

本レポートで扱う主な質問

  • 消化管用OTC医薬品市場の世界市場規模は？
  • 2025-2033年における世界の消化管用OTC医薬品市場の予想成長率は？
  • 世界の消化管用OTC医薬品市場を牽引する主要因は何か？
  • 世界の消化管用OTC医薬品市場に対するCOVID-19の影響は？
  • 世界の消化管用OTC医薬品市場における主要地域は？
  • 世界の消化管用OTC医薬品市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の消化管用OTC医薬品市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：薬剤クラス別

  • 下剤
  • 消化管がん治療
  • 胃酸抑制剤
  • 下痢止め
  • プロトンポンプ阻害剤
  • H2阻害剤
  • 胃酸中和剤
  • 腸抗炎症
  • 制吐剤

第7章 市場内訳：適応症別

  • 胃食道逆流症（GERD）または胸焼け
  • 便秘
  • 下痢
  • 乗り物酔い
  • その他

第8章 市場内訳：エンドユーザー別

  • 病院
  • クリニック
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boehringer Ingelheim GmbH
    • Johnson & Johnson
    • Prestige Consumer Healthcare Inc.
    • Purdue Pharma L.P
    • Sanofi
    • Zydus Lifesciences Limited
図表

List of Figures

  • Figure 1: Global: Gastrointestinal OTC Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Gastrointestinal OTC Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Gastrointestinal OTC Drugs Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Gastrointestinal OTC Drugs Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: Gastrointestinal OTC Drugs Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Gastrointestinal OTC Drugs Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Gastrointestinal OTC Drugs (Laxatives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Gastrointestinal OTC Drugs (Laxatives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Gastrointestinal OTC Drugs (Gastrointestinal Cancer Treatments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Gastrointestinal OTC Drugs (Gastric Acid Reducers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Gastrointestinal OTC Drugs (Anti-Diarrheal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Gastrointestinal OTC Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Gastrointestinal OTC Drugs (H2 Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Gastrointestinal OTC Drugs (Gastric Acid Neutralizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Gastrointestinal OTC Drugs (Bowel Anti-Inflammatory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Gastrointestinal OTC Drugs (Gastroesophageal Reflux Disease (GERD) or Heartburn) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Gastrointestinal OTC Drugs (Constipation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Gastrointestinal OTC Drugs (Constipation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Gastrointestinal OTC Drugs (Diarrhea) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Gastrointestinal OTC Drugs (Diarrhea) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Gastrointestinal OTC Drugs (Motion Sickness) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Gastrointestinal OTC Drugs (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Gastrointestinal OTC Drugs (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Gastrointestinal OTC Drugs (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Gastrointestinal OTC Drugs (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Gastrointestinal OTC Drugs (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Gastrointestinal OTC Drugs (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Gastrointestinal OTC Drugs (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Gastrointestinal OTC Drugs (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: North America: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: North America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: United States: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: United States: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Canada: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Canada: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Asia-Pacific: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Asia-Pacific: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: China: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: China: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Japan: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Japan: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: India: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: India: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: South Korea: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: South Korea: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Australia: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Australia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Indonesia: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Indonesia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Europe: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Europe: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Germany: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Germany: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: France: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: France: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: United Kingdom: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: United Kingdom: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Italy: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Italy: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Spain: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Spain: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Russia: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Russia: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Latin America: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Latin America: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Brazil: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Brazil: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Mexico: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Mexico: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Middle East and Africa: Gastrointestinal OTC Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Middle East and Africa: Gastrointestinal OTC Drugs Market: Breakup by Country (in %), 2024
  • Figure 88: Middle East and Africa: Gastrointestinal OTC Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Gastrointestinal OTC Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Gastrointestinal OTC Drugs Industry: Value Chain Analysis
  • Figure 91: Global: Gastrointestinal OTC Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gastrointestinal OTC Drugs Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 3: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 4: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Gastrointestinal OTC Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Gastrointestinal OTC Drugs Market: Competitive Structure
  • Table 7: Global: Gastrointestinal OTC Drugs Market: Key Players
目次
Product Code: SR112025A7781

The global gastrointestinal OTC drugs market size reached USD 43.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 62.2 Billion by 2033, exhibiting a growth rate (CAGR) of 3.82% during 2025-2033. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market.

Gastrointestinal over-the-counter (OTC) drugs refer to non-prescription medications that alleviate gastrointestinal symptoms and promote overall digestive wellness. It includes laxatives, antacids, H2 blockers, proton pump inhibitors (PPIs), anti-emetics, bowel anti-inflammatory, and anti-diarrheal medications. Gastrointestinal OTC drugs are widely used to treat indigestion, constipation, heartburn, diarrhea, motion sickness, acid reflux, nausea, irritable bowel syndrome (IBS), and abdominal pain. It is a cost-effective, convenient, and easily accessible product that provides immediate relief, enhances patient comfort, and allows self-management. Gastrointestinal OTC drugs also aid in improving gut health, restoring beneficial bacteria, preventing future complications, and minimizing the severity of various symptoms, such as pain, bloating, abdominal discomfort, and vomiting.

Gastrointestinal OTC Drugs Market Trends:

The rising prevalence of gastrointestinal disorders due to sedentary lifestyles and unhealthy eating habits is one of the key factors providing a thrust to the market growth. Gastrointestinal OTC drugs are widely used to treat infections, dyspepsia, acute diarrhea, heartburn, gastroesophageal reflux disease (GERD), constipation, bloating, and morning sickness. Furthermore, the increasing product applications to improve digestion, promote gut health, and ensure proper breakdown and absorption of nutrients, owing to the growing awareness among the masses regarding digestive health, is providing an impetus to the market growth. In line with this, the emerging trends of self-care and consumer empowerment to manage well-being and prevent future health complications are acting as another growth-inducing factor. Additionally, the recent development of advanced formulations, such as effervescent tablets, liquids, suspensions, film strips, and chewable products, which enhances the effectiveness of the drugs, increases absorption, and reduces the frequency of dosing, is positively influencing the market growth. Besides this, the introduction of convenient and travel-friendly packaging, such as blister packs, resealable pouches, and single-dose packets, is propelling the market growth. Apart from this, the rising consumer preference for non-invasive treatments is facilitating product demand to manage common digestive issues and provide immediate relief. Moreover, aggressive promotional and branding campaigns by several manufacturers through television (TV) commercials, social media, influencer marketing, and celebrity endorsement is strengthening the market growth. Other factors, including the rising geriatric populations, increasing expenditure capacities of consumers, and easy availability of products across e-commerce platforms, are anticipated to drive the market growth.

Key Market Segmentation:

Drug Class Insights:

  • Laxatives
  • Gastrointestinal Cancer Treatments
  • Gastric Acid Reducers
  • Anti-Diarrheal
  • Proton Pump Inhibitors
  • H2 Inhibitors
  • Gastric Acid Neutralizers
  • Bowel Anti-Inflammatory
  • Anti-Emetics

Indication Insights:

  • Gastroesophageal Reflux Disease (GERD) or Heartburn
  • Constipation
  • Diarrhea
  • Motion Sickness
  • Others

End User Insights:

  • Hospitals
  • Clinics
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for gastrointestinal OTC drugs. Some of the factors driving the North America gastrointestinal OTC drugs market included the rising prevalence of gastrointestinal disorders, increasing awareness among the masses, and various product innovations.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global gastrointestinal OTC drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boehringer Ingelheim GmbH, Johnson & Johnson, Prestige Consumer Healthcare Inc., Purdue Pharma L.P, Sanofi, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the global gastrointestinal OTC drugs market?
  • 2.What is the expected growth rate of the global gastrointestinal OTC drugs market during 2025-2033?
  • 3.What are the key factors driving the global gastrointestinal OTC drugs market?
  • 4.What has been the impact of COVID-19 on the global gastrointestinal OTC drugs market?
  • 5.What are the key regions in the global gastrointestinal OTC drugs market?
  • 6.Who are the key players/companies in the global gastrointestinal OTC drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gastrointestinal OTC Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Laxatives
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Gastrointestinal Cancer Treatments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gastric Acid Reducers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Anti-Diarrheal
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Proton Pump Inhibitors
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 H2 Inhibitors
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Gastric Acid Neutralizers
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Bowel Anti-Inflammatory
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Anti-Emetics
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Gastroesophageal Reflux Disease (GERD) or Heartburn
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Constipation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Motion Sickness
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Prestige Consumer Healthcare Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Purdue Pharma L.P
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Sanofi
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Zydus Lifesciences Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.